Suche
Kategorie
985 Treffer
×
Forschungsprojekte
×
aktiv
×
Johannes Gutenberg-Universität Mainz
×
Theologische Fakultät Trier
×
Hochschule für Wirtschaft und Gesellschaft Ludwigshafen
×
Technische Hochschule Bingen
- TREASURE (#1234)
- Alt, Jürgen; (2020 - 2040)
- RE-MIND2 (#1246)
- Heß, Georg; (2020 - 2040)
- Claudin 6 BNT211-01 CLDN6 (#1220)
- Wagner-Drouet, Eva; (2020 - 2040)
- MGD006 (#798)
- Radsak, Markus; (2020 - 2040)
- APX001-202 (#790)
- Teschner, Daniel; (2020 - 2040)
- OroCheck
- Heß, Georg; (2020 - 2040)
- cGvHD-Register (#621)
- Wagner-Drouet, Eva; (2020 - 2040)
- BO42592 (#1294)
- Alt, Jürgen; (2020 - 2040)
- CLAUDENTIFY6 - Claudin-Screening von soliden Tumoren (#1256)
- Wagner-Drouet, Maria; (2020 - 2040)
- Thrombose PNH (#1296)
- Radsak, Markus; (2020 - 2040)
- ACE-536-LTFU-001 (#1155)
- Radsak, Markus; (2020 - 2040)
- AFM13-202 REDIRECT (#1174)
- Heß, Georg; (2020 - 2040)
- AMLSG 30-18 (#752)
- Kühn, Michael; (2020 - 2040)
- RAGNAR CAN2002 (#1185)
- Desuki, Alexander; (2020 - 2040)
- Concordance of PD-L1 expression in breast carcinoma between primarius and metastasis
- Schmidt, Marcus; Stewen, Kathrin; (2020 - 2025)
- Natalee
- Schmidt, Marcus; Krajnak, Slavomir; (2020 - 2026)
- Beatcc
- Battista, Marco; Hasenburg, Annette; (2020 - 2025)
- Praegnant
- Schmidt, Marcus; (2020 - 2025)
- GCT3013-01 (#1216)
- Heß, Georg; (2020 - 2040)
- Biomarker Penis
- Tsaur, Igor; Thomas, Anita; Kölling, Felix; (2020 - 2026)
- CINC424A2X01B - 2005 (#1207)
- Radsak, Markus; (2020 - 2040)
- GRN163L (Imetelstat) in transfusion-dependent subjects (#1158)
- Radsak, Markus; (2020 - 2040)
- ABP-2019 (#1162)
- Alt, Jürgen; (2020 - 2040)
- Gravitas 309 - JAK1 Inhibitor in cGVHD first line (#1137)
- Wagner-Drouet, Maria; (2020 - 2040)
- SFB-TR-128 Project B09: Rebalancing cortical neuronal hyperactivity as a new treatment strategy in neuroinflammation
- Ellwardt, Erik; Stroh, Albrecht; (2020 - 2024)
- SFB-TR-128 Project B04: Unraveling the role of myeloid and metabolism in clinical progression of MS
- Bittner, Stefan; Bopp, Tobias; (2020 - 2024)
- Don't Perish
- Kerz, Thomas; Neulen, Axel; Wesp, Dominik; (2020 - 2025)
- VITDALIZE
- Kerz, Thomas; Neulen, Axel; Wesp, Dominik; (2020 - 2025)
- KRT-232-101 (#1127)
- Radsak, Markus; (2020 - 2040)
- COPE-Mediziner*innenstudie: Prognoseübermittlung an Eltern Frühgeborener
- Kidszun, André; Mildenberger, Eva; Stümer, Hannah; Urschitz, Michael; König, Jochem; Hammerle, Florian; Forth, Fiona; Neuweiler, Philip; (2020 - 2024)
- SFB-TR-128 project B12: Balancing glutamate and cation channel signaling in inflammatory neuronal injury
- Bittner, Stefan; (2020 - 2024)
- SFB-TR-128 Project B15: Spatiotemporal effects of IL-4 on CNS repair during neuroinflammation
- Zipp, Frauke; Vogelaar, Francisca; (2020 - 2024)
- Design und Erfolgsfaktoren von Social Commerce am Beispiel der Weinbranche
- Ehm, Laura; (ab 2020)
- NEO-MILK – Muttermilchbanken: Implementierung und Förderung der Laktation auf deutschen neonatologischen Intensivstationen
- Mildenberger, Eva; Schmitz, Katharina; Antabi, Theresa; (2020 - 2025)
- Neo-Milk
- Eva, Mildenberger; Schmitz, Katharina; (2020 - 2024)
- PANIC - Elterliche Lebensqualität nach neonatologischer Intensivbehandlung
- Schönfeld, Mascha; Kidszun, André; Mildenberger, Eva; (2020 - 2024)
- FASCINATION (#1180)
- Radsak, Markus; (2020 - 2040)
- Charly - Haplo-Tx bei NHL (#1206)
- Wagner-Drouet, Maria; (2020 - 2040)
- SFB-TR-128 Project B05: Topological patterns of damage and compensation in chronic neuroinflammation
- Groppa, Sergiu; Muthuraman, Muthuraman; (2020 - 2024)
- TRADE-hypo (#1177)
- Alt, Jürgen; (2020 - 2040)
- Digitale Edition der Keilschrifttexte aus Haft Tappeh
- Homburg, Timo; Bruhn, Kai-Christian; Prechel, Doris; (2019 - 2025)
- Die Quecksilbergrube "Treue Zuversicht".
- Haupt, Peter; (ab 2019)
- Prospektionen auf dem Hérapel (Frankreich, Dép. Moselle)
- Haupt, Peter; (ab 2019)
- V114 in recipients of allogeneic hematopoietic stem cell transplant (#796)
- Teschner, Daniel; (2019 - 2040)
- A Phase I/II clinical trial for TCR modified T cells MDG1011in HR myeloid and lymphatic neoplasms (#799)
- Wagner-Drouet, Maria; (2019 - 2040)
- GMMG HD7 Trial (#789)
- Munder, Markus; Goldschmidt, Hartmut; (2019 - 2040)
- ARROW 2 Trial (#1116)
- Munder, Markus; Weisel, Katja; (2019 - 2040)
- Tumorantigene bei AML/MDS/MM (#1168)
- Wagner-Drouet, Maria; (2019 - 2040)
- DLBCL CD20+ ImbruVeRCHOP-Trial (#757)
- Heß, Georg; (2019 - 2040)
- INCB 01158-206 (#1151)
- Munder, Markus; (2019 - 2040)
- IMI.Gel001 (#1264)
- Radsak, Markus; (2019 - 2040)
- MPNSG (BiO)-Project in BCR-ABL1-negative Myeloid Neoplasms (#1141)
- Radsak, Markus; (2019 - 2040)
- Vision (#731)
- Alt, Jürgen; (2019 - 2040)
- ADVANCE II (#512)
- Wagner-Drouet, Maria; (2019 - 2040)
- BMS CA17-078: A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle Invasive Bladder Cancer
- Tsaur, Igor; Höfner, Thomas; Jäger, Wolfgang; (2019 - 2025)
- rrMCL PI3K Inhibitor_ CITADEL-205 / INCB 50465-205 (#767)
- Heß, Georg; (2019 - 2040)
- TOP-ART, NCT-PMO-1603 (#774)
- Kindler, Thomas; (2019 - 2040)
- GS-US-352-4365 (#788)
- Kindler, Thomas; (2019 - 2040)
- BMBF (FKZ: 13GW0403B): New Generation of an Artificial Skin Kit: Actively Induced Tissue Reconstruction (SKIN-ENERGY)
- Wang, Xiaohong; Müller, E.G.; (2019 - 2024)
- GO29781 (#795)
- Heß, Georg; (2019 - 2040)
- OLYMP-1 (#770)
- Heß, Georg; (2019 - 2040)
- DUO-O
- Hasenburg, Annette; Almstedt, Katrin; (2019 - 2027)
- Molecular and clinical analysis of papillary thyroid carcinoma
- Musholt, J.; Staubitz, Julia; (2018 - 2025)
- Stellar Teens - CNTO1275PSO4056 - NIS
- Staubach-Renz, Petra; (2018 - 2024)
- GMMG-CONCEPT (#693)
- Munder, Markus; (2018 - 2025)
- PRAN-16-52 (#650)
- Kindler, Thomas; (2018 - 2040)
- Römisch-Mittelalterliche Wurzeln von Stadecken
- Haupt, Peter; (ab 2018)
- Allo-MM-PostCy-Study (#763)
- Wagner-Drouet, Maria; (2018 - 2040)
- FLT3 Maintenance (#702)
- Wagner-Drouet, Maria; (2018 - 2040)
- SAKK 36/13 (#730)
- Heß, Georg; (2018 - 2040)
- 1336.11 (#662)
- Alt, Jürgen; (2018 - 2040)
- ACE-LY-308 (#679)
- Heß, Georg; (2018 - 2040)
- LB-Y5-025 (#751)
- Teschner, Daniel; (2018 - 2040)
- Impassion 030 Alexandra
- Schmidt, Marcus; Almstedt, Katrin; (2018 - 2026)
- AGO Ovar 22: A Phase III, multicenter, randomized, study of Atezolizumab versus placebo administered in combination with Paclitaxel, Carboplatin and Bevacizumab to patients with newly diagnosed Stage III or Stage IV ovarian, Fallopian Tube or primary Peritoneal Cancer
- Hasenburg, Annette; Battista, Marco; (2018 - 2025)
- Römisch-frühmittelalterliche Besiedlung im Umfeld der Kaiserpfalz Ingelheim
- Haupt, Peter; (ab 2017)
- Epigenetische Kontrolle leukämogener Genexpression durch Menin und MLL1-Komplexpartner-Proteine
- Kühn, Michael; (2017 - 2024)
- Frühe Eisengewinnung im Ingelheimer Wald
- Haupt, Peter; (ab 2017)
- MaiCo-MR
- Emrich, Tilman; (2017 - 2025)
- Ruxo-BEAT trial (#593)
- Kindler, Thomas; (2017 - 2040)
- Untersuchung zum HLA-DP-Mismatch bei allogener Stammzelltransplantation (#725)
- Wagner-Drouet, Maria; (2017 - 2040)
- JETS-Studie (#681)
- Wagner-Drouet, Maria; (2017 - 2040)
- AML_MDM2 antagonist, WO29519 Cytarabine (#643)
- Kindler, Thomas; (2017 - 2040)
- DETECT V /Chevendo
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- COMPASS
- Battista, Marco; Hasenburg, Annette; (2017 - 2025)
- Merit
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- ImPassion131
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- Fandango
- Battista, Marco; (2017 - 2025)
- Ruxo-allo-Studie (#631)
- Wagner-Drouet, Maria; (2017 - 2040)
- Precycle
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- SHAPE
- Hasenburg, Annette; Roxanna, Schwab; Seeger, Alexander; (2017 - 2025)
- REGSA
- Battista, Marco; Hasenburg, Annette; (2017 - 2025)
- Olympia
- Schmidt, Marcus; Battista, Marco; (2017 - 2025)
- BrainMet
- Schmidt, Marcus; (2017 - 2025)